European Companies Maintain China Manufacturing Presence Amid EU Derisking Push European Manufacturers Maintain China Production Amid EU DeRisking Efforts Immunic Appoints Erik Lundgren as CEO Amid Phase 3 Multiple Sclerosis Trial Progress HRS Aluglaze Shares Surge 6 After Strong Q4 FY26 Results Revenue Up 60 Profit Nearly Doubles Commodity Investing in 2026 The Case for Targeted Sector Strategies South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Disputes CMDB Q1 2026 Earnings EPS of 051 Reported Amid Stock Decline Talphera Inc TLPH Q1 2026 Earnings Narrower Loss Surprises Analysts as Company Advances Pipeline AERT Q1 2026 Earnings EPS Breaks into Positive Territory Stock Rallies PERI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter CWK Q1 2026 Earnings Earnings Per Share Exceeds Estimates Stock Rises Slightly UNM Q1 2026 Earnings EPS Surpasses Estimates as Stock Finishes Flat Daedalus Special Acquisition Corp Warrants DSACW Remain Flat at 045 as Market Awaits Catalysts Alphatec Holdings ATEC Slips 169 as Stock Tests Key Support Zone Montrose Environmental Group MEG Surges Over 5 as Environmental Services Sector Gains Momentum Pembina Pipeline PBA Slides 155 as Energy Sector Faces Headwinds Niu Technologies NIU Slides 2 to 240 Key Support Levels Under Pressure Analyst Report Highlights Resilience of HF Sinclair Corp Amid Refining Market Dynamics NMIH Q1 2026 Earnings EPS Beats Consensus by 18 Stock Slightly Lower Kura Oncology Stock Slides Testing Key Support Levels Amid Biotech Sector Weakness National Healthcare Properties Preferred Stock NHPAP Edges Higher Amid Steady Trading iPower Inc IPW Surges Above Support Eyes Resistance at 446 Hologic Inc HOLX Holds Steady at 7601 Consolidation Between Key Support and Resistance K2 Capital Acquisition Rights KTWOR Holds Steady at 019 as Market Awaits Catalyst Ciena Corporation CIEN Consolidates Near 584 After Slight Pullback Vox Royalty Corp VOXR Surges Over 5 Key Support and Resistance Levels in Focus Fate Therapeutics Surges Over 10 as Biotech Sector Shows Signs of Life FATE